These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients. Chousterman S; Chousterman M; Reinert P; Thang MN Biomed Pharmacother; 1983; 37(4):176-80. PubMed ID: 6198003 [TBL] [Abstract][Full Text] [Related]
6. [Serum 2-5 oligoadenylate synthetase activity in infectious diseases and collagen diseases in childhood]. Arai T; Yamamoto H; Sakamoto M; Eda N; Matsumoto T; Ikei K; Hashimoto H; Seki T; Ohtani T; Ohishi T Kaku Igaku; 1991 Feb; 28(2):197-203. PubMed ID: 2051656 [No Abstract] [Full Text] [Related]
7. Detection of 2',5' oligoadenylate synthetase activity in acute viral hepatitis with special reference to histologic features in the acute stage. Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Kashima K; Sokawa Y Gastroenterol Jpn; 1991 Apr; 26(2):162-9. PubMed ID: 1710193 [TBL] [Abstract][Full Text] [Related]
9. [Changes of serum 2',5'-oligoadenylate synthetase activity and neopterin during interferon treatment for chronic hepatitis C]. Daito K; Suou T; Kawasaki H Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):981-5. PubMed ID: 7563914 [No Abstract] [Full Text] [Related]
10. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B. Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079 [TBL] [Abstract][Full Text] [Related]
11. Decreased interferon binding capacity of peripheral blood mononuclear cells during interferon treatment of chronic hepatitis B with special reference to (2'-5') oligoadenylate synthetase activity. Shindo M; Iwata A; Okuno T; Matsumoto M; Takeda M; Arai K; Sokawa Y Gastroenterol Jpn; 1989 Dec; 24(6):670-5. PubMed ID: 2481600 [TBL] [Abstract][Full Text] [Related]
12. Assay and the levels of 2-5A-synthetase in lymphocytes of patients with viral, bacterial and autoimmune diseases. Buffet-Janvresse C; Magard H; Robert N; Hovanessian AG Ann Immunol (Paris); 1983; 134D(2):247-58. PubMed ID: 6197930 [TBL] [Abstract][Full Text] [Related]
13. [Investigation of 2'-5' oligoadenylate synthetase activity in peripheral blood mononuclear leukocytes in Behçet's disease]. Ohno S; Kotake S; Hirose S; Matsuda H; Fujii N Nippon Ganka Gakkai Zasshi; 1986 May; 90(5):771-4. PubMed ID: 2428227 [No Abstract] [Full Text] [Related]
14. Elevated levels of 2',5'-oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during acute exacerbation of chronic hepatitis B. Shindo M; Okuno T; Arai K; Matsumoto M; Takeda M; Takino T; Sokawa Y Hepatology; 1989 May; 9(5):715-9. PubMed ID: 2468593 [TBL] [Abstract][Full Text] [Related]
15. 2',5'-Oligoadenylate and 2',5'-oligoadenylate phosphodiesterase in human plasma. Sawai H; Ishibashi K; Itoh M; Watanabe S Biochem Biophys Res Commun; 1984 Dec; 125(3):1061-6. PubMed ID: 6517934 [TBL] [Abstract][Full Text] [Related]
16. 2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases. Hylton W; Cayley J; Dore C; Denman AM Ann Rheum Dis; 1986 Mar; 45(3):220-4. PubMed ID: 3954470 [TBL] [Abstract][Full Text] [Related]
17. [Changes in serum levels of beta 2-microglobulin, neopterin and 2',5'-oligoadenylate synthase activity during clearance of hepatitis B virus with or without acute phase in transaminases]. Carreño García V; Hernández-Guío C; Bartolomé Nebreda J; Quiroga Estévez JA Rev Esp Enferm Dig; 1993 Mar; 83(3):169-75. PubMed ID: 7683894 [TBL] [Abstract][Full Text] [Related]
18. 2'5' Oligoadenylate synthetase assay in human diseases. Its clinical value in viral liver diseases. Chousterman S; Chousterman M; Poitrine A; Chaput JC; Thang MN Prog Clin Biol Res; 1985; 202():431-8. PubMed ID: 3008173 [No Abstract] [Full Text] [Related]